STXS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

ST

Mkt Cap

$101.7M

Volume

817.15K

Next Earnings

November 10th

Loading chart

ST

STXSStereotaxis, Inc. Common Stock

STXS

Pay with—

Available Balance0.00

ST

Mkt Cap

$105.2M

Volume

817.15K

Next Earnings

November 10th

Chart Financials Earnings News About Insider Filings

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity MattersIntuitive Surgical submitted a next-generation flexible robotic endoscope to the FDA for 510(k) clearance, marking expansion into gastrointestinal care. The platform combines expertise from da Vinci surgical systems and Ion lung biopsy platform but remains in early development with no near-term revenue expected. Success will depend on regulatory approval, clinical evidence, and physician adoption.Zacks Investment Research · Oct 13, 2026

Stereotaxis Eyes Billions In Market Opportunity With Robocath TakeoverStereotaxis announced a definitive agreement to acquire Robocath, a developer of robotic technologies for interventional cardiology and neurointerventions. The acquisition is expected to contribute approximately $2 million in annual revenue in the first year and reach breakeven by year three. The deal includes a $20 million upfront payment with up to $25 million in contingent payments tied to regulatory and commercial milestones, with closing expected in mid-2026. Stereotaxis plans to pursue regulatory submissions in the US and Europe within two years and expand into electrophysiology applications.Benzinga · Apr 15, 2026

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026Stereotaxis announced it will release its 2025 fourth quarter and full year financial results on March 9, 2026, followed by a conference call at 4:30 p.m. ET to discuss results and corporate developments. The company is a leader in surgical robotics for minimally invasive endovascular intervention.GlobeNewswire Inc. · Feb 12, 2026

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025Stereotaxis will release its Q3 2025 financial results on November 11, 2025, and host a conference call at 4:30 p.m. ET to discuss company results and developments.GlobeNewswire Inc. · Oct 21, 2025

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025Stereotaxis, a leader in surgical robotics, will release its Q1 2025 financial results on May 12, 2025 and host a conference call to discuss the company's performance and developments.GlobeNewswire Inc. · Apr 22, 2025

Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc.The global magnetic ablation catheters market is expected to grow significantly, reaching $1.1 billion by 2035, driven by advancements in technology and the rising prevalence of cardiovascular diseases. Key factors driving growth include the increasing adoption of minimally invasive procedures and continued investment in healthcare infrastructure and R&D.GlobeNewswire Inc. · Feb 20, 2025

Medical Robots Market Report: Technological Advancements in Medical Industry and Growth of AI to Boosts the Demand | Future Market Insights, Inc.The global medical robot market is set to witness significant growth, driven by technological advancements, increased demand for minimally invasive surgeries, and the rising adoption of robotics in healthcare. The market is expected to grow from $11.5 billion in 2024 to $38.7 billion by 2034, at a CAGR of 12.9%.GlobeNewswire Inc. · Sep 5, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart TreatmentThe most advanced robotic cardiac ablation lab opens at Penn Presbyterian Medical Center.GlobeNewswire Inc. · May 29, 2024

Stereotaxis (STXS) Gets CE Recertification for Approved ProductsStereotaxis' (STXS) receives updated EU Quality Management System Certificate, which demonstrates compliance with MDR.Zacks Investment Research · May 27, 2024

Stereotaxis' (STXS) RMN System to Aid in Treating ArrhythmiasStereotaxis (STXS) announces the completion of treatment of first heart rhythm patients with its Genesis Robotic Magnetic Navigation system in Southern Italy.Zacks Investment Research · May 24, 2024

to start trading

ST

STXSStereotaxis, Inc. Common Stock

STXS

Pay with—

Available Balance0.00

Your PositionYou don't own any STXS yet.

Related Tickers

Earnings